维生素C联合维生素E治疗非酒精性脂肪肝的系统综述
Systematic Review of Vitamin C Combined with Vitamin E in the Treatment of Nonalcoholic Fatty Liver
摘要: 非酒精性脂肪肝(non-alcoholic fatty liver disease, NAFLD)是肝脏疾病的常见病因，是全球最常见的慢性肝病，其特点是肝脏脂肪变性，可进展为终末期肝病。维生素E的应用对于NAFLD的病人有一定的治疗作用，长期以来广泛应用于临床。近年来，维生素C联合维生素E在NAFLD的病人中应用较多，但对于其确切疗效尚未完全达成一致意见。本文就维生素C联合维生素E治疗非酒精性脂肪肝(NAFLD)的研究进展做一系统综述。
Abstract: Non-alcoholic fatty liver disease (NAFLD) is a common cause of liver disease and the most common chronic liver disease in the world. It is characterized by hepatic steatosis and can progress to end-stage liver disease. The application of vitamin E has a certain therapeutic effect on patients with NAFLD, and has been widely used in clinic for a long time. In recent years, vitamin C combined with vitamin E has been widely used in patients with NAFLD, but the exact efficacy has not been fully agreed. This paper reviews the research progress of vitamin C combined with vitamin E in the treatment of nonalcoholic fatty liver disease (NAFLD).
文章引用：韩荣双, 单梦琛, 刘婷, 田字彬, 荆雪. 维生素C联合维生素E治疗非酒精性脂肪肝的系统综述[J]. 临床医学进展, 2021, 11(10): 4727-4731. https://doi.org/10.12677/ACM.2021.1110694

参考文献

[1] Sumida, Y. and Yoneda, M. (2018) Current and Future Pharmacological Therapies for NAFLD/NASH. Journal of Gastroenterology, 53, 362-376. [Google Scholar] [CrossRef] [PubMed]
[2] Angelico, F., Del Ben, M., Conti, R., Francioso, S., Feole, K., Maccioni, D., Antonini, T.M. and Alessandri, C. (2003) Non-Alcoholic Fatty Liver Syndrome: A Hepatic Consequence of Common Metabolic Diseases. Journal of Gastroenterology and Hepatology, 18, 588-594. [Google Scholar] [CrossRef] [PubMed]
[3] Del Ben, M., Polimeni, L., Baratta, F., Pastori, D. and Angelico, F. (2017) The Role of Nutraceuticals for the Treatment of Non-Alcoholic Fatty Liver Disease. British Journal of Clinical Pharmacology, 83, 88-95. [Google Scholar] [CrossRef] [PubMed]
[4] Younossi, Z.M. (2019) Non-Alcoholic Fatty Liver Disease—A Global Public Health Perspective. Journal of Hepatology, 70, 531-544. [Google Scholar] [CrossRef] [PubMed]
[5] 王宇, 郑锦锋. 非酒精性脂肪肝营养干预的研究进展[J]. 医学研究生学报, 2014, 27(1): 99-101.
[6] Wei, J., Lei, G.H., Fu, L., Zeng, C., Yang, T. and Peng, S.F. (2016) Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults. PLoS ONE, 11, e0147985. [Google Scholar] [CrossRef] [PubMed]
[7] Ivancovsky-Wajcman, D., Fliss-Isakov, N., Salomone, F., Webb, M., Shibolet, O., Kariv, R. and Zelber-Sagi, S. (2019) Dietary Vitamin E and C Intake Is Inversely Associated with the Severity of Nonalcoholic Fatty Liver Disease. Digestive and Liver Disease, 51, 1698-1705. [Google Scholar] [CrossRef] [PubMed]
[8] El Hadi, H., Vettor, R. and Rossato, M. (2018) Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth? Antioxidants (Basel), 7, 12. [Google Scholar] [CrossRef] [PubMed]
[9] 赖荣陶, 陈成伟. 维生素E与慢性肝病的治疗[J]. 肝脏, 2007, 12(6): 508-509.
[10] Buettner, G.R. (1993) The Pecking Order of Free Radicals and Antioxidants: Lipid Peroxidation, Alpha-Tocopherol, and Ascorbate. Archives of Biochemistry and Biophysics, 300, 535-543. [Google Scholar] [CrossRef] [PubMed]
[11] Ipsen, D.H., Tveden-Nyborg, P. and Lykkesfeldt, J. (2014) Does Vitamin C Deficiency Promote Fatty Liver Disease Development? Nutrients, 6, 5473-5499. [Google Scholar] [CrossRef] [PubMed]
[12] Ashraf, N.U. and Sheikh, T.A. (2015) Endoplasmic Reticulum Stress and Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease. Free Radical Research, 49, 1405-1418. [Google Scholar] [CrossRef] [PubMed]
[13] Ooi, G.J., Meikle, P.J., Huynh, K., Earnest, A., Roberts, S.K., Kemp, W., Parker, B.L., Brown, W., Burton, P. and Watt, M.J. (2021) Hepatic Lipidomic Remodeling in Severe Obesity Manifests with Steatosis and Does Not Evolve with Non-Alcoholic Steatohepatitis. Journal of Hepatology, 75, 524-535. [Google Scholar] [CrossRef] [PubMed]
[14] Sanyal, A.J., Chalasani, N., Kowdley, K.V., McCullough, A., Diehl, A.M., Bass, N.M., Neuschwander-Tetri, B.A., Lavine, J.E., Tonascia, J., Unalp, A., et al. (2010) Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis. The New England Journal of Medicine, 362, 1675-1685. [Google Scholar] [CrossRef] 
[15] Manne, V., Handa, P. and Kowdley, K.V. (2018) Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clinical Liver Disease, 22, 23-37. [Google Scholar] [CrossRef] [PubMed]
[16] Harrison, S.A., Torgerson, S., Hayashi, P., Ward, J. and Schenker, S. (2003) Vitamin E and Vitamin C Treatment Improves Fibrosis in Patients with Nonalcoholic Steatohepatitis. American Journal of Gastroenterology, 98, 2485-2490. [Google Scholar] [CrossRef] [PubMed]
[17] Kawanaka, M., Nishino, K., Nakamura, J., Suehiro, M., Goto, D., Urata, N., Oka, T., Kawamoto, H., Nakamura, H., Yodoi, J., et al. (2013) Treatment of Nonalcoholic Steatohepatitis with Vitamins E and C: A Pilot Study. Hepatic Medicine: Evidence and Research, 5, 11-16. [Google Scholar] [CrossRef] 
[18] Schuster, S., Cabrera, D., Arrese, M. and Feldstein, A.E. (2018) Triggering and Resolution of Inflammation in NASH. Nature Reviews Gastroenterology & Hepatology, 15, 349-364. [Google Scholar] [CrossRef] [PubMed]
[19] Qi, A.Q., Li, Y., Liu, Q., Si, J.Z., Tang, X.M., Zhang, Z.Q., Qi, Q.D. and Chen, W.B. (2015) Thioredoxin Is a Novel Diagnostic and Prognostic Marker in Patients with Ischemic Stroke. Free Radical Biology & Medicine, 80, 129-135. [Google Scholar] [CrossRef] [PubMed]
[20] Eslam, M., Newsome, P.N., Sarin, S.K., Anstee, Q.M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun, W.V., Dufour, J.F., Schattenberg, J.M., et al. (2020) A New Definition for Metabolic Dysfunction-Associated Fatty Liver Disease: An International Expert Consensus Statement. Journal of Hepatology, 73, 202-209. [Google Scholar] [CrossRef] [PubMed]

为你推荐